FDA approves new drug for COPD

The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD). Read more at

Outpatient care of patients with COPD

Controlling symptoms and preventing exacerbations are the key to patient quality of life. Takeaways: Nurses must be able to identify patients with chronic obstructive pulmonary disease (COPD) early…

Reducing readmissions in in COPD patients

A preventable and treatable lung disorder of adults, chronic obstructive pulmonary disease (COPD) is one of the most common causes of hospitalizations and readmissions. It affects 15 million Americans; nearly one in five hospital patients older than age…

The ABCs of COPD

“I am a 59-year-old female recently diagnosed with Stage 2 COPD and chronic bronchitis. I smoked for 22 years. I have been hospitalized twice in the last seven…

Reader Survey

Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.